Related Experiment Videos
Vaginal bleeding disturbances and implantable contraceptives
Martha Hickey1, Catherine d'Arcangues
1Department of Reproductive Science and Medicine, Imperial College School of Medicine at St. Mary's, London W2 1PG, UK. m.hickey@ic.ac.uk
Contraception
|February 28, 2002
Summary
Modern implantable contraceptives offer long-term fertility control but often cause irregular vaginal bleeding. Understanding and managing these bleeding disturbances is key to improving user satisfaction and continuation rates.
Area of Science:
- Reproductive Health
- Contraception
- Gynecology
Background:
- Implantable contraceptives provide effective, long-term fertility regulation for up to five years.
- Current devices release low doses of progestogens, frequently leading to altered vaginal bleeding patterns.
- Irregular bleeding, prolonged bleeding, and amenorrhea are common side effects, impacting user acceptance.
Purpose of the Study:
- To review vaginal bleeding disturbances associated with modern implantable contraceptives.
- To discuss the implications of these bleeding patterns on method use and discontinuation.
- To explore potential mechanisms and therapies for managing these side effects.
Main Methods:
- Literature review of studies on implantable contraceptives and bleeding patterns.
- Analysis of evidence regarding the pathophysiology of breakthrough bleeding.
- Review of therapeutic interventions for bleeding disturbances.
Main Results:
- Disruption of vaginal bleeding patterns is a near-universal issue with implantable contraceptives.
- Emerging evidence suggests increased endometrial vascular fragility may cause breakthrough bleeding.
- Various therapies exist for managing bleeding disturbances, with varying efficacy.
Conclusions:
- Vaginal bleeding disturbances are a significant factor influencing the use and discontinuation of implantable contraceptives.
- Understanding the mechanisms, such as endometrial vascular fragility, is crucial for developing better management strategies.
- Effective therapies are needed to improve user satisfaction and adherence to long-acting reversible contraception.